Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23andMe, genetic testing
23andMe customer? Here's what to know about the privacy of your genetic data.
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
23andMe customer? What to know about the privacy of your genetic data.
23andMe
, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO
Anne
Wojcicki
has said she intends to take the company private ...
What 23andMe business troubles could mean for millions of users' genetic data
On Tuesday, 23andMe released its latest earnings report, showing revenue dipped 12% in the last quarter and share prices fell. The company has faced additional struggles over the past several months,
With 23andMe Struck by Layoffs, Can You Delete Genetic Data? Here's What We Know
In the wake of a big data breach and a sizable new round of layoffs, 23andMe's handling of sensitive personal data is in the spotlight.
What 23andMe business troubles could mean for users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers' DNA and other data. The company announced Monday that it would lay off around 40% of its workforce -- about 200 employees -- and close its drug development arm in an attempt to cut costs.
Mozilla
20m
23andMe announces restructuring, layoffs and review of therapeutic program
Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...
News Nation on MSN
1h
23andMe lays off 40% of workers, reports losses amid uncertain future
Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of ...
1d
on MSN
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
Hosted on MSN
8h
23andMe Cuts 40% of Staff as Revenue Falls
But it’s not just staffing changes:
23andMe
is also shutting down its entire therapeutics division, which had been working ...
1d
on MSN
23andMe cuts 40% of its workforce and discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
1d
on MSN
23andMe cuts 40% of its workforce, discontinues all therapy programs
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Hosted on MSN
1d
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...
1d
23andMe cuts 40% of its workforce
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
2d
23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
Hosted on MSN
2d
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company
23andMe
said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...
Yahoo Finance
1d
Q2 2024 23andMe Holding Co. Earnings Call
Anne
Wojcicki
; Chairman of the Board, President, Chief Executive Officer, Co-Founder;
23andMe
Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer;
23andMe
...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback